Kento Morozumi, Yoshihide Kawasaki, Tomonori Sato, Masamitsu Maekawa, Shinya Takasaki, Shuichi Shimada, Takanari Sakai, Shinichi Yamashita, Nariyasu Mano, Akihiro Ito. Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism. Metabolites. 2024. 14. 3. 170
Tensei Hirasawa, Masafumi Kikuchi, Shinya Takasaki, Masaki Kumondai, Yu Sato, Toshihiro Sato, Eishi Imoto, Yoshihiro Hayakawa, Masamitsu Maekawa, Nariyasu Mano. High throughput LC/ESI-MS/MS method for simultaneous analysis of 20 oral molecular-targeted anticancer drugs and the active metabolite of sunitinib in human plasma. Heliyon. 2023. 9. 6. e16926-e16926
Hirasawa Tensei, Kikuchi Masafumi, Takasaki Shinya, Kumondai Masaki, Sato Yu, Sato Toshihiro, Imoto Eishi, Hayakawa Yoshihiro, Maekawa Masamitsu, Mano Nariyasu. Shifting the linear range of the calibration curves for the quantification of oral molecular-targeted anticancer drugs and the active metabolite in human plasma using LC-ESI-MS/MS. Medical Mass Spectrometry. 2022. 6. 1. 52-63
Kento Morozumi, Yoshihide Kawasaki, Masamitsu Maekawa, Shinya Takasaki, Tomonori Sato, Shuichi Shimada, Naoki Kawamorita, Shinichi Yamashita, Koji Mitsuzuka, Nariyasu Mano, et al. Prediction model for recurrence of RCC by comparing pre- and post-operative urinary metabolite concentrations. Cancer science. 2021
Naoto Ishikawa, Hanae Oshikiri, Shinya Takasaki, Masafumi Kikuchi, Taku Obara, Kazutoshi Akasaka, Masaki Matsuura, Hiroaki Yamaguchi, Nariyasu Mano. Enhancement and evaluation of a prescription audit system for direct oral anticoagulants using a check sheet. Journal of Pharmaceutical Health Care and Sciences. 2021. 7. 1. 22-22